Geron Corp. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Geron Corp.

GERN 1.235

-3.5%

3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Savant	12/30/2024 11:08:56 AM
	of 3576

Geron’s stock has surged over 58% year-to-date following the success of its groundbreaking product, RYTELO. Its potential for further success in Europe and as a life-changing treatment for myeloid hematologic malignancies makes it a hot pick for investors in the healthcare sector. Geron (GERN) Stock Surges on Game-Changing New Treatment - TipRanks.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next